The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cattle Vaccines Market Research Report 2025
Synopsis
One of the most common questions in cow/calf production is what vaccines are necessary on an annual basis to keep the herd healthy.
The global Cattle Vaccines market was valued at US$ 1566.3 million in 2023 and is anticipated to reach US$ 2407.3 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cattle Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cattle Vaccines.
Report Scope
The Cattle Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cattle Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cattle Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
Zoetis
Boehringer Ingelheim
Ceva
Jinyu Bio-Technology
CAHIC
TECON
Segment by Type
Live Attenuated Vaccine
Inactivated Vaccine
Others
Segment by Application
Government Tender
Market Sales
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cattle Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
One of the most common questions in cow/calf production is what vaccines are necessary on an annual basis to keep the herd healthy.
The global Cattle Vaccines market was valued at US$ 1566.3 million in 2023 and is anticipated to reach US$ 2407.3 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cattle Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cattle Vaccines.
Report Scope
The Cattle Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cattle Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cattle Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
Zoetis
Boehringer Ingelheim
Ceva
Jinyu Bio-Technology
CAHIC
TECON
Segment by Type
Live Attenuated Vaccine
Inactivated Vaccine
Others
Segment by Application
Government Tender
Market Sales
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cattle Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cattle Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Live Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cattle Vaccines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cattle Vaccines Market Perspective (2019-2030)
2.2 Cattle Vaccines Growth Trends by Region
2.2.1 Global Cattle Vaccines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cattle Vaccines Historic Market Size by Region (2019-2024)
2.2.3 Cattle Vaccines Forecasted Market Size by Region (2025-2030)
2.3 Cattle Vaccines Market Dynamics
2.3.1 Cattle Vaccines Industry Trends
2.3.2 Cattle Vaccines Market Drivers
2.3.3 Cattle Vaccines Market Challenges
2.3.4 Cattle Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cattle Vaccines Players by Revenue
3.1.1 Global Top Cattle Vaccines Players by Revenue (2019-2024)
3.1.2 Global Cattle Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Cattle Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cattle Vaccines Revenue
3.4 Global Cattle Vaccines Market Concentration Ratio
3.4.1 Global Cattle Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cattle Vaccines Revenue in 2023
3.5 Cattle Vaccines Key Players Head office and Area Served
3.6 Key Players Cattle Vaccines Product Solution and Service
3.7 Date of Enter into Cattle Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cattle Vaccines Breakdown Data by Type
4.1 Global Cattle Vaccines Historic Market Size by Type (2019-2024)
4.2 Global Cattle Vaccines Forecasted Market Size by Type (2025-2030)
5 Cattle Vaccines Breakdown Data by Application
5.1 Global Cattle Vaccines Historic Market Size by Application (2019-2024)
5.2 Global Cattle Vaccines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cattle Vaccines Market Size (2019-2030)
6.2 North America Cattle Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cattle Vaccines Market Size by Country (2019-2024)
6.4 North America Cattle Vaccines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cattle Vaccines Market Size (2019-2030)
7.2 Europe Cattle Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cattle Vaccines Market Size by Country (2019-2024)
7.4 Europe Cattle Vaccines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cattle Vaccines Market Size (2019-2030)
8.2 Asia-Pacific Cattle Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cattle Vaccines Market Size by Region (2019-2024)
8.4 Asia-Pacific Cattle Vaccines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cattle Vaccines Market Size (2019-2030)
9.2 Latin America Cattle Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cattle Vaccines Market Size by Country (2019-2024)
9.4 Latin America Cattle Vaccines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cattle Vaccines Market Size (2019-2030)
10.2 Middle East & Africa Cattle Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cattle Vaccines Market Size by Country (2019-2024)
10.4 Middle East & Africa Cattle Vaccines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Detail
11.1.2 Merck Animal Health Business Overview
11.1.3 Merck Animal Health Cattle Vaccines Introduction
11.1.4 Merck Animal Health Revenue in Cattle Vaccines Business (2019-2024)
11.1.5 Merck Animal Health Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Cattle Vaccines Introduction
11.2.4 Zoetis Revenue in Cattle Vaccines Business (2019-2024)
11.2.5 Zoetis Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Cattle Vaccines Introduction
11.3.4 Boehringer Ingelheim Revenue in Cattle Vaccines Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Ceva
11.4.1 Ceva Company Detail
11.4.2 Ceva Business Overview
11.4.3 Ceva Cattle Vaccines Introduction
11.4.4 Ceva Revenue in Cattle Vaccines Business (2019-2024)
11.4.5 Ceva Recent Development
11.5 Jinyu Bio-Technology
11.5.1 Jinyu Bio-Technology Company Detail
11.5.2 Jinyu Bio-Technology Business Overview
11.5.3 Jinyu Bio-Technology Cattle Vaccines Introduction
11.5.4 Jinyu Bio-Technology Revenue in Cattle Vaccines Business (2019-2024)
11.5.5 Jinyu Bio-Technology Recent Development
11.6 CAHIC
11.6.1 CAHIC Company Detail
11.6.2 CAHIC Business Overview
11.6.3 CAHIC Cattle Vaccines Introduction
11.6.4 CAHIC Revenue in Cattle Vaccines Business (2019-2024)
11.6.5 CAHIC Recent Development
11.7 TECON
11.7.1 TECON Company Detail
11.7.2 TECON Business Overview
11.7.3 TECON Cattle Vaccines Introduction
11.7.4 TECON Revenue in Cattle Vaccines Business (2019-2024)
11.7.5 TECON Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
